Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
62 USD | -3.88% |
|
-10.12% | +100.06% |
Jul. 03 | Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week | MT |
Jul. 03 | Insmed Incorporated Announces Additional Positive Results from the ASPEN Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+100.06% | 10B | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.82% | 25.93B | |
-24.33% | 19.27B | |
-19.58% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating